These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 33624865
1. Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats. Fenn J, Kenny PJ, Scudder CJ, Hazuchova K, Gostelow R, Fowkes RC, Forcada Y, Church DB, Niessen SJM. J Vet Intern Med; 2021 Mar; 35(2):823-833. PubMed ID: 33624865 [Abstract] [Full Text] [Related]
2. Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats. van Bokhorst KL, Galac S, Kooistra HS, Valtolina C, Fracassi F, Rosenberg D, Meij BP. J Vet Intern Med; 2021 Mar; 35(2):834-842. PubMed ID: 33621385 [Abstract] [Full Text] [Related]
3. Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism. Miceli DD, García JD, Pompili GA, Rey Amunategui JP, Ferraris S, Pignataro OP, Guitelman M. J Feline Med Surg; 2022 Dec; 24(12):1238-1244. PubMed ID: 35133181 [Abstract] [Full Text] [Related]
6. Successful treatment of acromegaly in a diabetic cat with transsphenoidal hypophysectomy. Meij BP, Auriemma E, Grinwis G, Buijtels JJ, Kooistra HS. J Feline Med Surg; 2010 May; 12(5):406-10. PubMed ID: 20417901 [Abstract] [Full Text] [Related]
7. Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus. Scudder CJ, Hazuchova K, Gostelow R, Church DB, Forcada Y, Fowkes RC, Niessen SJ. J Feline Med Surg; 2021 Feb; 23(2):131-137. PubMed ID: 32684121 [Abstract] [Full Text] [Related]
9. Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism. Keyte SV, Kenny PJ, Forcada Y, Church DB, Niessen SJ. J Vet Intern Med; 2016 Jul; 30(4):973-82. PubMed ID: 27425382 [Abstract] [Full Text] [Related]
11. Pasireotide for the Medical Management of Feline Hypersomatotropism. Scudder CJ, Gostelow R, Forcada Y, Schmid HA, Church D, Niessen SJ. J Vet Intern Med; 2015 Jul; 29(4):1074-80. PubMed ID: 25945588 [Abstract] [Full Text] [Related]
12. Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with overweight/obesity. Miceli DD, Jaliquias A, Gallelli MF, García JD, Vecino C, Rey Amunategui JP, Pompili GA, Espiñeira IM, Más J, Pignataro OP. Domest Anim Endocrinol; 2024 Oct; 89():106858. PubMed ID: 38830275 [Abstract] [Full Text] [Related]
18. Effect of insulin treatment on circulating insulin-like growth factor I and IGF-binding proteins in cats with diabetes mellitus. Strage EM, Sundberg M, Holst BS, Andersson Franko M, Ramström M, Fall T, Lewitt M. J Vet Intern Med; 2018 Sep; 32(5):1579-1590. PubMed ID: 30112786 [Abstract] [Full Text] [Related]
19. Feline Comorbidities: Hypersomatotropism-induced diabetes in cats. Scudder C, Church D. J Feline Med Surg; 2024 Feb; 26(2):1098612X241226690. PubMed ID: 38323402 [Abstract] [Full Text] [Related]